Nicotinamide supplementation in diabetic nonalcoholic fatty liver disease patients: randomized controlled trial

Nicotinamide supplementation in diabetic nonalcoholic fatty liver disease patients: randomized controlled trial

Background: Nicotinamide has been reported to protect against liver steatosis and metabolic imbalances in nonalcoholic fatty liver disease (NAFLD) in animal models. Objectives: The objective was to investigate the efficacy and safety of nicotinamide supplementation in diabetic NAFLD patients. Design...

Full description

Bibliographic Details
Main Authors: Rasha R. El-Kady, Amani K. Ali, Lamia M. El Wakeel, Nagwa A. Sabri, May A. Shawki
Format: Article
Language:English
Published: SAGE Publishing 2022-02-01
Series:Therapeutic Advances in Chronic Disease
Online Access:https://doi.org/10.1177/20406223221077958

Similar Items

Similar Items